EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Korro Bio's enterprise value is $38.93 Mil.
Korro Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $4.82 Mil. Therefore, Korro Bio's EV-to-Revenue for today is 8.07.
The historical rank and industry rank for Korro Bio's EV-to-Revenue or its related term are showing as below:
KRRO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 9.7 Med: 59.24 Max: 140.89
Current: 8.07
During the past 4 years, the highest EV-to-Revenue of Korro Bio was 140.89. The lowest was 9.70. And the median was 59.24.
KRRO's EV-to-Revenue is ranked worse than 55.37% of 997
companies
in the Biotechnology industry
Industry Median: 7.42
vs KRRO: 8.07
As of today (2025-05-30), Korro Bio's stock price is $11.00.
Korro Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.51. Therefore, Korro Bio's PS Ratio for today is 21.40.
Korro Bio EV-to-Revenue Historical Data
The historical data trend for Korro Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Korro Bio's EV-to-Revenue
For the Biotechnology subindustry, Korro Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Korro Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Korro Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Korro Bio's EV-to-Revenue falls into.
Korro Bio's current Enterprise Value is $38.93 Mil.
Korro Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korro Bio's share price for today is $11.00.
Korro Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korro Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Korro Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRRO has been successfully added to your 